Rubius Therapeutics Inc
RUBY
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-12,665,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.56 |
| Beta | 2.21 |
| Outstanding Shares | 90,434,391 |
Return
| Return on Equity | -1544.83% |
|---|---|
| Return on Assets | -1013.21% |
| Return on Invested Capital | -1027.54% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.09 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.08 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.17 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Rubius Therapeutics Inc
CEO: Pablo Cagnoni